Drug Development Pharma - January 28, 2015
FDA Approves Generic Nexium
AstraZeneca’s extended protection period for the $3 billion-selling heartburn drug Nexium has come to an end, now that the U.S. Food and Drug Administration (FDA) has approved the first generic version of Nexium. Ivax Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceuticals USA, has won approval to market the medication in 20 and 40 milligram capsules. […]
